HPC Offered for PRESERVE Expansion
Ossium Health, Inc.
Summary
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Eligibility
- Age range
- 12–80 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if: Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks
Interventions
- OtherBone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)
The HOPE Program does not include any investigational drugs. The medicines and procedures in this program are standard of care for a transplant. Bone marrow cells from a deceased organ and tissue donor for use in your transplant is the only product offered to you by Ossium Health.
Locations (4)
- University of Alabama, BirminghamBirmingham, Alabama
- Henry Ford HealthDetroit, Michigan
- The Ohio State University Medical CenterColumbus, Ohio
- Tristar Centennial Medical CenterNashville, Tennessee